History-Maker SRK: First and Only Indian Actor to Sell 1 Million Ticket Sales in a Single Year in UK!

SRK in Pathaan , Jawan , Dunki broke all records

Shah Rukh Khan is breaking records one after another. After earning more than 1000 crore overseas in a single year, SRK has achieved another record.

SRK with Pathaan, Jawan and Dunki created another record

Yes, Shah Rukh Khan’s splendid success in 2023 has left no stone unturned in breaking box office records. After grossing 1000 crore overseas in a single year, Shah Rukh Khan’s three films Pathaan, Jawan and Dunki have sold 1 million tickets in the UK. SRK is the only Indian actor to do so.

Shah Rukh Khan delivered a spectacular performance at the box office in 2023 with his three movies, Pathaan, Jawan, and Dunki. All three movies crossed the gross collection of 2600 crore rupees.

His three movies had a footfall of 8.41 crore in 2023. With this, Shah Rukh Khan set another record for himself, as he is the only actor to have over 7 crore footfalls in a single year for three times. SRK had his first time in 1995 with 10.8 crore footfalls, followed by 1997 with 7.5 crore, and 2023 with 8.41 crore.

After being named the Indian of the year by CNN News 18, SRK was honoured with the SABSE TEZ ACTOR award by the AajTak Group. SRK expressed his heartfelt gratitude to his fans and the AajTak Group after winning the award

SRK working with Sanjay Leela Bhansali ( SLB ) ?

Shah Rukh is not Considering Inshallah from Bhansali There were also reports in Pinkvilla suggesting that Shah Rukh might take on the lead role in Sanjay Leela Bhansali’s Inshallah, a film that Salman Khan had previously walked out of due to differences with the director. The film is a mature love story set across two continents. However, a source close to SRK’s production house, who wished to remain anonymous, stated that Shah Rukh’s next project will be an action film. He is currently not interested in any drama films, including Inshallah. Therefore, any news to the contrary is false.

Read more here: